-+ 0.00%
-+ 0.00%
-+ 0.00%

Tempus AI Receives EU IVDR Certification for xR Cancer Profiling Test

PUBT·10/26/2026 12:32:02
Listen to the news
Tempus AI Receives EU IVDR Certification for xR Cancer Profiling Test
  • Tempus AI received EU IVDR certification for its xR RNA sequencing assay for solid tumor profiling as a Class C diagnostic device.
  • The certification supports continued EU access beyond the 2028 transition deadline for eligible legacy Class C devices.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610260830BIZWIRE_USPR_____20261026_BW148540) on October 26, 2026, and is solely responsible for the information contained therein.